Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care

NCT05155917 is registered in ClinicalTrials.gov with Changhua Christian Hospital as lead sponsor.

NCT NCT05155917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05155917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care
Lead sponsor
Changhua Christian Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2022
Completion date
January 31, 2024
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic ketoacidosis, hyperglycaemic crisis in diabetes mellitus, hyperglycaemic hyperosmolar nonketotic syndrome